NWBO stock price forecast outlines upside scenarios tied to successful Phase III trial results, which could fundamentally re-rate the stock valuation. Northwest Biotherapeutics, Inc. (NWBO) Stock Price, News ... Investors and industry observers will find timely updates on the company's dendritic cell therapy platform, which leverages patients' immune systems to target cancer. The curated news collection includes press releases about trial results, manufacturing advancements, and intellectual property expansions. Traders aligning with NWBO stock price forecast are monitoring RSI levels nearing 55, suggesting neither overbought nor oversold conditions.